Jefferies Downgrades Astria Therapeutics (ATXS) to Hold

Jefferies analyst Eun Yang downgraded Astria Therapeutics (NASDAQ: ATXS) from Buy to Hold with a price target of $13.00 (from $30.00).

For an analyst ratings summary and ratings history on Astria Therapeutics click here. For more ratings news on Astria Therapeutics click here.

Shares of Astria Therapeutics closed at $8.47 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
• Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities